Grindrの空売り状況は、投資家がGrindrの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Grindr (NYSE:GRND) 株価情報, 空売り情報

Grindr

Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.

Mid Cap

News

Movers

CRDO

DJTWW

ENVX

FIZZ

GLBE

GRND

KVYO

STAA

TGLS

先週、これらの中型株は最も優れた業績を発揮しました。あなたのポートフォリオには含まれていますか？

中小株式市場　今週注目の10銘柄

Grindr Inc

Earnings

Earnings Beats

CRMT

America's Car-Mart Q3 2025 GAAP EPS $0.37 Beats $0.10 Estimate, Sales $325.726M Beat $295.262M Estimate

PSTV

Plus Therapeutics Granted FDA Orphan Drug Designation for For Rhenium Obisbemeda In Leptomeningeal Metastases In Patients with Lung Cancer

United Microelectronics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>) shares are trading lower in the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44160040/umc-reports-sales-for-february-2025" rel="noreferrer noopener">premarket session on Thursday.</a>
The company reported February sales of NT$18.193B, up 4.25% year over year. January-February combined net sales were NT$38B, up 4.21% year over year.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, UMC stock has lost over 14% in the past year. Investors can gain exposure to the stock via National Security Emerging Markets Index ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSI#NASDAQ">NSI</a>) and&nbsp;SP Funds Trust SP Funds S&amp;P Global Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPTE#NYSE">SPTE</a>).
In a press release dated January 21, United Microelectronics co-President Jason Wang said he finds the semiconductor market poised for another year of growth, driven by strong demand for AI servers as well as increasing semiconductor content in smartphones,<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43091628/umc-reports-fourth-quarter-2024-results" rel="noreferrer noopener"> PCs, and other electronic devices.</a>
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44145025/dine-brands-q4-earnings-beat-estimates-sales-dip-on-lower-franchise-revenues" rel="noreferrer noopener">Dine Brands Q4 Earnings: Sales Dip, EPS Miss, Negative Comps For Applebee&#8217;s, IHOP And More</a>
United Microelectronics continues investing in technological innovation and expanding its advanced packaging offering.
The 22/28nm portfolio remained the most significant contributor, with revenue augmenting&nbsp;by 15%&nbsp;in 2024. Tape-outs for 22nm products are accelerating, and Wang expects to see higher revenue contributions from 2025 onwards.
In its fourth-quarter report, United Microelectronics&nbsp;said it <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">expects first-quarter</a> wafer shipments to remain flat and ASP in USD to decrease by mid-single-digit&nbsp;percentage quarter-over-quarter.
It also expects capacity utilization to be in the 70% range. United Microelectronics expects a cash-based&nbsp;2025 capex of $1.8 billion.
Price Action: UMC shares are trading lower by 2.65% to $6.62 premarket at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44138085/donald-trumps-bitcoin-ethereum-xrp-reserve-is-imperfect-but-bullish-says-bitwises-matt-hougan" target="_blank" rel="noreferrer noopener">Donald Trump&#8217;s Bitcoin, Ethereum, XRP Reserve Is ‘Imperfect&#8217; But Bullish, Says Bitwise&#8217;s Matt Hougan</a></li>
</ul>
Image via Shutterstock.

Equities

Markets

General

SP Funds Trust SP Funds S&P Global Technology ETF

SPTE

What's Going On With United Microelectronics Stock Today?

Astronaut Sunita Williams said on Tuesday that the International Space Station (ISS) is at its &#8220;prime&#8221; and right now would probably not be the right time to deorbit it, contrary to the opinions of SpaceX CEO Elon Musk.
What Happened: &#8220;&#8230;this place is ticking. It&#8217;s just really amazing. So I would say we&#8217;re actually in our prime right now. We&#8217;ve got all the power, all of the facilities up and operating,&#8221; Williams said in a live on Tuesday from ISS. 
Williams said that now may not be the right time to deorbit the station and choosing to deorbit the station around 2030 as planned would be ideal. 
&#8220;I think that&#8217;s probably really accurate, because we should make the most of this space station for our taxpayers and for all of our international partners, and hold our obligations and do that world-class science that this laboratory is capable of,&#8221; she said. 
Williams has been up at the station since June and is slated to return to Earth as early as later this month.
Musk&#8217;s Take: Musk in February opined that preparations <a href="https://www.benzinga.com/general/space/25/02/43875844/spacex-ceo-elon-musk-calls-for-deorbiting-space-station-ahead-of-timeline-in-2027-lets-go-to-mars">must start already for deorbiting ISS.</a> 
"It has served its purpose. There is very little incremental utility," Musk said in a post on X, formerly Twitter. "Let's go to Mars," the billionaire said, calling for a human-operated base on Mars instead of the low Earth orbit.
"The decision is up to the President, but my recommendation is as soon as possible," Musk said while also recommending that the station be deorbited two years from now, or in 2027.
Why It Matters: The ISS&nbsp;is operated by space agencies from the U.S., Europe, Japan, Canada, and Russia. All countries except Russia have committed to operating the station until 2030.&nbsp;The station has spent about 25 years in orbit and over 270 astronauts have visited it to date.
NASA&nbsp;<a href="https://www.benzinga.com/news/24/07/39574766/spacex-overtakes-ula-in-military-space-missions-as-vulcan-centaur-rocket-experiences-delays" target="_blank" rel="noreferrer noopener">chose SpaceX</a>&nbsp;to develop and deliver the U.S. Deorbit vehicle (USDV) to deorbit the space station and ensure a lack of risk to populated areas in late June. SpaceX will develop the deorbit spacecraft under the contract valued at $843 million and NASA will take ownership afterward and operate it through the mission.
The space agency previously said that the deorbit spacecraft would move the station out of orbit and into a remote area of an ocean at the end of its operations around 2030.
Both the spacecraft and the station are expected to break up through the process of re-entry into Earth&#8217;s atmosphere. Any remnants will subsequently fall harmlessly into the ocean as part of the plan.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44101333/fords-mustang-mach-e-leads-companys-us-ev-sales-in-feb-but-trump-tariffs-threaten-future" target="_blank" rel="noreferrer noopener">Ford's Mustang Mach-E Leads Company's US EV Sales In Feb But Trump Tariffs Threaten Future</a></li>
</ul>
Photo courtesy: Shutterstock

SPACE

Tech

Elon Musk Thinks ISS Has Served Its Purpose And Should Be Deorbited, But Sunita Williams Says It Is Still At Its Prime: 'This Place Is Ticking. It's Just Really Amazing'

D. Boral Capital analyst Jesse Sobelson maintains Crexendo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) with a Buy and raises the price target from $7 to $10.

Price Target

Analyst Ratings

CXDO

D. Boral Capital Maintains Buy on Crexendo, Raises Price Target to $10

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) from Buy to Buy.

Reiteration

HALO

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeuticsto Buy

D. Boral Capital analyst Jesse Sobelson initiates coverage on Aduro Clean Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUR#NASDAQ">ADUR</a>) with a Buy rating and announces Price Target of $50.

Initiation

ADUR

D. Boral Capital Initiates Coverage On Aduro Clean Technologies with Buy Rating, Announces Price Target of $50

CORRECTION: Needham analyst David Saxon reiterates Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) from Hold to Hold. (Firm Name change From H.C. Wainwright to Needham)

NVST

CORRECTION: Needham Reiterates Hold on Envista Holdingsto Hold (Firm Name change From H.C. Wainwright to Needham)

Biotech

Health Care

EVGN

During Q4 2024 And The Beginning Of 2025, Evogene Established An Expense Reduction Plan, To Better Align With Its Strategic Goals, Leading To A Reduction Of ~30% In Headcount, To Be Completed By The End Of Q1 2025

D. Boral Capital analyst Jason Kolbert maintains Hoth Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) with a Buy and maintains $5 price target.

HOTH

D. Boral Capital Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target

HC Wainwright &amp; Co. analyst David Saxon reiterates Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) from Hold to Hold.

HC Wainwright & Co. Reiterates Hold on Envista Holdingsto Hold

Evogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.72) by 108.33 percent. This is a 104.62 percent increase over losses of $(1.30) per share from the same period last year. The company reported quarterly sales of $1.61 million which missed the analyst consensus estimate of $3.63 million by 55.56 percent. This is a 178.72 percent increase over sales of $578.00 thousand the same period last year.

Evogene Q4 2024 GAAP EPS $0.06 May Not Be Comparable To $(0.72) Estimate, Sales $1.61M Miss $3.63M Estimate

BXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, today announced that on March 5, 2025, it completed the formation of a joint venture to develop 290 Coles Street, a full-block, 1.75 acre site between Coles Street, Jersey Avenue, and 16th and 17th Streets in Jersey City, New Jersey. The property will be developed into a 670-unit market-rate residential project offering panoramic views of the Hudson River and Manhattan skyline.
BXP and its partners will execute the approximately $400M development through a newly formed joint venture with CrossHarbor Capital ("CrossHarbor") and Albanese Organization and its partner (collectively, "Albanese"). BXP owns a 19% common equity interest in the venture, Albanese owns a 14% common equity interest, and CrossHarbor Capital owns the remaining 67% common equity interest. BXP will also provide $65M in preferred equity as additional project funding. BNY, as Administrative Agent and Arranger, led the financing of a $225M senior secured construction loan in a three-bank deal that includes U.S. Bank National Association and Banco Bilbao Vizcaya Argentaria as Co-Syndication Agents.

BXP Forms Joint Venture for $400M Jersey City Residential Project, Secures $225M Construction Loan

Superior Industries Projects FY25 Net Sales Of $1.30B-$1.40B Vs. $1.31B Estimate

VSAT

Viasat Reveals First-Of-Its-Kind Demonstration Of Direct-To-Device Connectivity For The Automotive Sector

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>) with a Buy and maintains $23 price target.

TARA

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

Rosenblatt analyst Kevin Cassidy maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Buy and maintains $140 price target.

MRVL

Rosenblatt Maintains Buy on Marvell Tech, Maintains $140 Price Target

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Kamada (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMDA#NASDAQ">KMDA</a>) with a Buy and maintains $11 price target.

KMDA

HC Wainwright & Co. Reiterates Buy on Kamada, Maintains $11 Price Target

WIIM

BABA

Alibaba shares are trading higher after Alibaba Cloud announced its QwQ-32B compact reasoning model.

LASE

Laser Photonics, Fonon And Brokk Expand Nuclear Decontamination Alliance; Showcas Advanced Laser Cleaning Solutions At WM Symposia 2025

Press Releases

Grindr Announces Date of Third Quarter 2024 Financial Results Earnings Call

Grindr Inc. Reports Third Quarter 2024 Revenue Growth of 27%, Raises Revenue Guidance

Grindr to Participate in the Raymond James 2024 TMT & Consumer Conference

Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature

Grindr Unveils 2025 Product Roadmap, Including Six New Intent-Based Travel and AI Personalization Products

Grindr Inc. Expects to Beat 2024 Revenue Outlook and Announces Redemption of Warrants

Grindr Inc. Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants

Grindr Announces Date of Fourth Quarter and Full Year 2024 Financial Results Earnings Call

Grindr to Participate in Upcoming Investor Conferences

Grindr Inc. Delivers 33% Full Year 2024 Revenue Growth

Autohome Inc. American Depositary Shares, each representing four class A ordinary shares.

Comments

Grindr

空売り

Grindr (NYSE:GRND) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル